British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis

2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis

(2018) Anne-Kathrin Rausch Osthoff et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

(2018) Christian Dejaco et al.   ANNALS OF THE RHEUMATIC DISEASES

Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients

(2018) Hubert de Boysson et al.   AUTOIMMUNITY REVIEWS

Comparative effectiveness of 18F-FDG PET-CT and contrast-enhanced CT in the diagnosis of suspected large-vessel vasculitis

(2018) Sriram Vaidyanathan et al.   BRITISH JOURNAL OF RADIOLOGY

Ophthalmic manifestations of giant cell arteritis

(2018) Ivana Vodopivec et al.   RHEUMATOLOGY

Large-vessel giant cell arteritis: diagnosis, monitoring and management

(2018) Matthew J Koster et al.   RHEUMATOLOGY

Does leflunomide have a role in giant cell arteritis? An open-label study

(2018) Alojzija Hočevar et al.   CLINICAL RHEUMATOLOGY

Trial of Tocilizumab in Giant-Cell Arteritis

(2017) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Large vessel dilatation in giant cell arteritis: a different subset of disease?

(2017) Francesco Muratore et al.   ARTHRITIS CARE & RESEARCH

Exercise in Takayasu Arteritis: Effects on Inflammatory and Angiogenic Factors and Disease-Related Symptoms

(2017) Diego S. Oliveira et al.   ARTHRITIS CARE & RESEARCH

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis

(2017) Carol A. Langford et al.   Arthritis & Rheumatology

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

(2016) Cindy Strehl et al.   ANNALS OF THE RHEUMATIC DISEASES

Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression

(2016) Carmelo Scarpignato et al.   BMC Medicine

The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis

(2016) Karin Jakobsson et al.   BMC MUSCULOSKELETAL DISORDERS

The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study

(2016) Raashid Luqmani et al.   HEALTH TECHNOLOGY ASSESSMENT

Risk Factors for Permanent Visual Loss in Biopsy-proven Giant Cell Arteritis: A Study of 339 Patients

(2016) E. Liozon et al.   JOURNAL OF RHEUMATOLOGY

Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

(2016) Peter M Villiger et al.   LANCET

Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis

(2016) Delphine Lariviere et al.   MEDICINE

Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)

(2016) B. Bienvenu et al.   REVUE DE MEDECINE INTERNE

High-Resolution Magnetic Resonance Imaging of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Cohort Study

(2016) Maxime Rhéaume et al.   Arthritis & Rheumatology

2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

(2015) Christian Dejaco et al.   ANNALS OF THE RHEUMATIC DISEASES

Guideline panels should not GRADE good practice statements

(2015) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?

(2015) Andreas P. Diamantopoulos et al.   RHEUMATOLOGY

Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients

(2015) A. Iorio et al.   BMJ-British Medical Journal

Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients

(2015) A. Iorio et al.   BMJ-British Medical Journal

3T MRI Reveals Extra- and Intracranial Involvement in Giant Cell Arteritis

(2014) S. Siemonsen et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

2014 ESC Guidelines on the diagnosis and treatment of aortic diseases

(2014)   EUROPEAN HEART JOURNAL

Projected Worldwide Disease Burden from Giant Cell Arteritis by 2050

(2014) E. De Smit et al.   JOURNAL OF RHEUMATOLOGY

Relapses in Patients With Giant Cell Arteritis

(2014) Marco A. Alba et al.   MEDICINE

Giant Cell Arteritis: Diagnostic Accuracy of MR Imaging of Superficial Cranial Arteries in Initial Diagnosis—Results from a Multicenter Trial

(2014) Thorsten Klink et al.   RADIOLOGY

Large-vessel giant cell arteritis: a cohort study

(2014) F. Muratore et al.   RHEUMATOLOGY

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis

(2014) Eleana Ntatsaki et al.   RHEUMATOLOGY

Large vessel vasculitis in elderly patients: early diagnosis and steroid-response evaluation with FDG-PET/CT and contrast-enhanced CT

(2014) Go Muto et al.   RHEUMATOLOGY INTERNATIONAL

QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies

(2013) Penny F. Whiting   ANNALS OF INTERNAL MEDICINE

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases

(2013) N Duru et al.   ANNALS OF THE RHEUMATIC DISEASES

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK

(2013) Joanna C Robson et al.   ANNALS OF THE RHEUMATIC DISEASES

Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial

(2013) Raphaèle Seror et al.   ANNALS OF THE RHEUMATIC DISEASES

GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations

(2013) Jeff Andrews et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Optimized glucocorticoid therapy: Teaching old drugs new tricks

(2013) Cindy Strehl et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Diagnostic Value of Color Doppler Ultrasonography of Temporal Arteries and Large Vessels in Giant Cell Arteritis: A Consecutive Case Series

(2013) Andreas P. Diamantopoulos et al.   ARTHRITIS CARE & RESEARCH

Leflunomide as a Corticosteroid-Sparing Agent in Giant Cell Arteritis and Polymyalgia Rheumatica: A Case Series

(2013) Andreas P. Diamantopoulos et al.   Biomed Research International

Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis

(2012) Sarah Louise Mackie et al.   ANNALS OF THE RHEUMATIC DISEASES

Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography

(2012) Sergio Prieto-González et al.   ANNALS OF THE RHEUMATIC DISEASES

Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis

(2012) Tanaz A Kermani et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series

(2012) T. Adizie et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis

(2011) Hisham M. Habib et al.   CLINICAL RHEUMATOLOGY

Application of GRADE: Making evidence-based recommendations about diagnostic tests in clinical practice guidelines

(2011) Jonathan Hsu et al.   Implementation Science

GRADE guidelines: 3. Rating the quality of evidence

(2011) Howard Balshem et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors

(2011) Sarah L. Mackie et al.   RHEUMATOLOGY

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

(2010) S. van Assen et al.   ANNALS OF THE RHEUMATIC DISEASES

Illustrated histopathologic classification criteria for selected vasculitis syndromes

(2010) J. T. Lie   ARTHRITIS AND RHEUMATISM

GRADE guidelines: 2. Framing the question and deciding on important outcomes

(2010) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Diagnostic value of T2-weighted imaging for the detection of superficial cranial artery inflammation in giant cell arteritis

(2010) Julia Geiger et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

BSR and BHPR guidelines for the management of giant cell arteritis

(2010) B. Dasgupta et al.   RHEUMATOLOGY

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

(2010) Jennifer M. Grossman et al.   ARTHRITIS CARE & RESEARCH

Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies

(2009) J. L. Brożek et al.   ALLERGY

BSR and BHPR guidelines for the management of polymyalgia rheumatica

(2009) B. Dasgupta et al.   RHEUMATOLOGY

Polymyalgia rheumatica and giant-cell arteritis

(2008) Carlo Salvarani et al.   LANCET

Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis

(2008) C. Salvarani et al.   RHEUMATOLOGY

Genomic and nongenomic effects of glucocorticoids

(2008) Cindy Stahn et al.   Nature clinical practice. Rheumatology

Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis

(2007) W. A. Schmidt et al.   RHEUMATOLOGY